Cargando…
Withholding methotrexate after COVID-19 vaccination: different strategies, same results? – Author's reply
Autores principales: | Mehta, Pankti, Ahmed, Sakir, Shenoy, Padmanabha, Skaria, Teny Grace, Paul, Aby |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691056/ https://www.ncbi.nlm.nih.gov/pubmed/36447939 http://dx.doi.org/10.1016/S2665-9913(22)00335-6 |
Ejemplares similares
-
Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel, assessor-masked, randomised controlled trials
por: Skaria, Teny Grace, et al.
Publicado: (2022) -
Withholding methotrexate after COVID-19 vaccination: different strategies, same results?
por: De Medeiros-Ribeiro, Ana C, et al.
Publicado: (2022) -
Switching to teleconsultation for rheumatology in the wake of the COVID-19 pandemic: feasibility and patient response in India
por: Shenoy, Padmanabha, et al.
Publicado: (2020) -
Effectiveness of delayed second dose of AZD1222 vaccine in patients with autoimmune rheumatic disease
por: Mehta, Pankti, et al.
Publicado: (2022) -
Correlates of breakthrough Omicron (B.1.1.529) infections in a prospective cohort of vaccinated patients with rheumatic diseases
por: Benny, Libin, et al.
Publicado: (2023)